160 related articles for article (PubMed ID: 31567943)
21. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.
Sample DC; Samadder NJ; Pappas LM; Boucher KM; Samowitz WS; Berry T; Westover M; Nathan D; Kanth P; Byrne KR; Burt RW; Neklason DW
BMC Gastroenterol; 2018 Jul; 18(1):115. PubMed ID: 30012100
[TBL] [Abstract][Full Text] [Related]
22. Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights.
Aelvoet AS; Buttitta F; Ricciardiello L; Dekker E
Best Pract Res Clin Gastroenterol; 2022; 58-59():101793. PubMed ID: 35988966
[TBL] [Abstract][Full Text] [Related]
23. Modulation by dietary factors in murine FAP models.
Paulsen JE
Toxicol Lett; 2000 Mar; 112-113():403-9. PubMed ID: 10720759
[TBL] [Abstract][Full Text] [Related]
24. Familial adenomatous polyposis.
Half E; Bercovich D; Rozen P
Orphanet J Rare Dis; 2009 Oct; 4():22. PubMed ID: 19822006
[TBL] [Abstract][Full Text] [Related]
25. Attenuated familial adenomatous polyposis (AFAP). A review of the literature.
Knudsen AL; Bisgaard ML; Bülow S
Fam Cancer; 2003; 2(1):43-55. PubMed ID: 14574166
[TBL] [Abstract][Full Text] [Related]
26. Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis.
Mutoh M; Akasu T; Takahashi M; Niho N; Yoshida T; Sugimura T; Wakabayashi K
Jpn J Clin Oncol; 2006 Mar; 36(3):166-71. PubMed ID: 16478792
[TBL] [Abstract][Full Text] [Related]
27. Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.
Giardiello FM; Offerhaus JA; Tersmette AC; Hylind LM; Krush AJ; Brensinger JD; Booker SV; Hamilton SR
Gut; 1996 Apr; 38(4):578-81. PubMed ID: 8707091
[TBL] [Abstract][Full Text] [Related]
28. [Colorectal cancer in familial adenomatous polyposis: Are there clinical predictive factors?].
de Campos FG; Nicácio De Freitas I; Imperiale AR; Seid VE; Perez RO; Nahas SC; Cecconello I
Cir Esp; 2010 Dec; 88(6):390-7. PubMed ID: 21056411
[TBL] [Abstract][Full Text] [Related]
29. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas.
Asano TK; McLeod RS
Cochrane Database Syst Rev; 2004; 2004(2):CD004079. PubMed ID: 15106236
[TBL] [Abstract][Full Text] [Related]
30. Nonampullary Duodenal Adenomas in Familial Adenomatous Polyposis and Sporadic Patients Lack the DNA Content Abnormality That Is Characteristic of the Adenoma-Carcinoma Sequence Involved in the Development of Other Gastrointestinal Malignancies.
Mohammed N; Rabinovitch PS; Wang D; Kővári BP; Mattis AN; Lauwers GY; Choi WT
Am J Surg Pathol; 2021 Dec; 45(12):1694-1702. PubMed ID: 34138799
[TBL] [Abstract][Full Text] [Related]
31. Cancer in Patients With Familial Adenomatous Polyposis: A Nationwide Danish Cohort Study With Matched Controls.
Karstensen JG; Bülow S; Højen H; Jelsig AM; Jespersen N; Andersen KK; Wewer MD; Burisch J; Pommergaard HC
Gastroenterology; 2023 Sep; 165(3):573-581.e3. PubMed ID: 37201686
[TBL] [Abstract][Full Text] [Related]
32. The impact of chromoendoscopy for surveillance of the duodenum in patients with MUTYH-associated polyposis and familial adenomatous polyposis.
Hurley JJ; Thomas LE; Walton SJ; Thomas-Gibson S; Haycock A; Suzuki N; Mort M; Williams G; Morgan M; Clark SK; Sampson JR; Dolwani S
Gastrointest Endosc; 2018 Oct; 88(4):665-673. PubMed ID: 29702101
[TBL] [Abstract][Full Text] [Related]
33. Can resistant starch and/or aspirin prevent the development of colonic neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 Study.
Mathers JC; Mickleburgh I; Chapman PC; Bishop DT; Burn J;
Proc Nutr Soc; 2003 Feb; 62(1):51-7. PubMed ID: 12740057
[TBL] [Abstract][Full Text] [Related]
34. Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.
Park J; Kim JW; Park H; Park SY; Kim TH; Kim SW; Oh YL; Chung JH
Thyroid; 2019 Nov; 29(11):1606-1614. PubMed ID: 31469036
[No Abstract] [Full Text] [Related]
35. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
[TBL] [Abstract][Full Text] [Related]
36. Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
Cruz-Correa M; Diaz-Algorri Y; Mendez V; Vazquez PJ; Lozada ME; Freyre K; Lathroum L; Gonzalez-Pons M; Hernandez-Marrero J; Giardiello F; Rodriguez-Quilichini S
Fam Cancer; 2013 Sep; 12(3):555-62. PubMed ID: 23460355
[TBL] [Abstract][Full Text] [Related]
37. The treatment of desmoid tumors associated with familial adenomatous polyposis: the results of a Japanese multicenter observational study.
Inoue Y; Ishida H; Ueno H; Kobayashi H; Yamaguchi T; Konishi T; Tomita N; Matsubara N; Ishida F; Hinoi T; Kanemitsu Y; Watanabe T; Sugihara K
Surg Today; 2017 Oct; 47(10):1259-1267. PubMed ID: 28251376
[TBL] [Abstract][Full Text] [Related]
38. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis.
Takayama T; Ohi M; Hayashi T; Miyanishi K; Nobuoka A; Nakajima T; Satoh T; Takimoto R; Kato J; Sakamaki S; Niitsu Y
Gastroenterology; 2001 Sep; 121(3):599-611. PubMed ID: 11522744
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival.
Järvinen HJ
Gut; 1992 Mar; 33(3):357-60. PubMed ID: 1314763
[TBL] [Abstract][Full Text] [Related]
40. Colonic and duodenal flat adenomas in children with classical familial adenomatous polyposis.
Cohen M; Thomson M; Taylor C; Donatone J; Quijano G; Drut R
Int J Surg Pathol; 2006 Apr; 14(2):133-40. PubMed ID: 16703174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]